Profile cover photo
Profile photo
Jenny Pereira
38 followers
38 followers
About
Posts

Post has attachment
Antigen Express on Cancer Immunotherapy and Peptides
In today's featured interview from TIDES 2014 , Eric von Hofe, Ph.D., President, Antigen Express , Inc. discusses peptides, cancer immunotherapy, peptide vaccines, and his experience at the TIDES 2014 event. He states that peptides constitute the minimum un...

Post has attachment
Advances in siRNA Developing Delivery Solutions
In today's featured interview from TIDES 2014 , Jared A. Gollob, M.D., Vice President, Clinical Research, Alnylam Pharmaceuticals , Inc. discusses exciting advances in siRNA.  He says there are several different delivery formulations and the company goes af...

Post has attachment
Application Space for Peptides
In today's featured interview from TIDES 2014 , Patrick C. Reid, Ph.D., Chief Scientific Officer, PeptiDream, Inc of Japan talks about how a lot of work involving peptides are not published yet. That kind if info is obtained in this type of conference. He a...

Post has attachment
Has disposable technology been tested on a large scale yet?
Biopharmaceutical Development and Production Week speaker Siddhartha Shrivastava, Ph.D., Senior Scientist, Downstream Process Development, Patheon recently took some time to sit down with us and discuss his upcoming presentation centered around downstream p...

Post has attachment
[Video] ALN-TTR Programs for Transthyretin Amyloidosis
In today's featured presentation from TIDES 2014 , Jared A. Gollob, M.D., Vice President of Clinical Research at Alnylam Pharmaceuticals , Inc. presents how explains how Transthyretin Amyloidosis is formed and how it develops throughout the body.  Transthyr...

Post has attachment

Post has attachment

Post has attachment
How much more cost effective is a disposal technology approach?
Biopharmaceutical Development and Production Week speaker Siddhartha Shrivastava, Ph.D., Senior Scientist, Downstream Process Development, Patheon recently took some time to sit down with us and discuss his upcoming presentation centered around downstream p...

Post has attachment
Why is disposable technology more appealing compared to conventional technology?
Biopharmaceutical Development and Production Week speaker Siddhartha Shrivastava, Ph.D., Senior Scientist, Downstream Process Development, Patheon recently took some time to sit down with us and discuss his upcoming presentation centered around downstream p...

Post has attachment
[Video] Breakthrough Status: Are You Ready?
In today's featured presentation from TIDES 2014, Jeffrey Baker, Ph.D., Deputy Director, Office of Biotechnology Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration talks about FDA SIA (Safety and Innovation Act). He present...
Wait while more posts are being loaded